Hepatic Disease

Gastroenterology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Valeo Pharmaceuticals
1 program
1
RedescaPhase 31 trial
Active Trials
NCT06153394Not Yet RecruitingEst. Feb 2028

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
Valeo PharmaceuticalsRedesca

Clinical Trials (1)

NCT06153394Valeo PharmaceuticalsRedesca

Prolonged Hypercoagulability Following Major Liver Resection for Malignancy

Start: Jun 2024Est. completion: Feb 2028
Phase 3Not Yet Recruiting

Related Jobs in Gastroenterology

Specialty Representative, Gastroenterology – Minneapolis, Minnesota

AbbVie
Remote
12h ago

Head of Drug Product Development

Ironwood Pharmaceuticals
Boston, Massachusetts, United States
14h ago
$246K - $287K/yr

Regulatory Affairs Associate

Ferring Pharmaceuticals
Istanbul, Turkey
Yesterday

Key Account Director, Diagnostics and Research

Tempus
Remote
Yesterday
$150K - $200K/yr

Senior Sterilization Validation Engineer (m/f/d)

Johnson & Johnson
Beerse, Antwerp, Belgium
Yesterday

Senior Financial Analyst - Supply Chain Finance & Transformation (m/f/d)

Johnson & Johnson
Norderstedt, Schleswig-Holstein, Germany
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space

Related Indications

Hepatic Impairment(79)Gastroesophageal Reflux Disease(37)Irritable Bowel Syndrome(29)Gastroesophageal Reflux(27)Liver Transplantation(24)Celiac Disease(23)Hepatic Insufficiency(22)Liver Cirrhosis(22)Gastroesophageal Reflux Disease (GERD)(14)Hepatic Encephalopathy(12)